CSL Behring sponsor HemoNED

26/01/2017

CSL Behring also agreed to sponsor the development of the HemoNED registry. For long-term continuation of the registry, additional funding will be provided by public-private collaborations with pharmaceutical industries that provide products for patients with hemophilia or associated bleeding disorders.